{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:14:26Z","timestamp":1790727266662,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010807","name":"Firat University Scientific Research Projects Management Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.psychres.2016.11.021","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T13:00:35Z","timestamp":1479301235000},"page":"84-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics"],"prefix":"10.1016","volume":"247","author":[{"given":"Alper","family":"Bas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Incir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba Ocek","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Emul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaatin","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2016.11.021_bib1","article-title":"Protective effect of Calligonum comosum on haloperidol-induced oxidative stress in rat","author":"Abdel-Sattar","year":"2012","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.psychres.2016.11.021_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"2000"},{"issue":"47","key":"10.1016\/j.psychres.2016.11.021_bib3","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.1073\/pnas.0608757103","article-title":"Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage","volume":"103","author":"Ames","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.psychres.2016.11.021_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0006-3223(99)00152-3","article-title":"Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms","volume":"46","author":"Andreasen","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2016.11.021_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.psychres.2016.11.021_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.psychres.2016.11.021_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.comppsych.2005.05.002","article-title":"Neuropsychological profile of cognitively impaired patients with schizophrenia. Compr Psychiatry. 47 (2), 136-143. damage","volume":"47","author":"Bozikas","year":"2006","journal-title":"Compr Psychiatry"},{"issue":"4-5","key":"10.1016\/j.psychres.2016.11.021_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/15216540051081010","article-title":"Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems","volume":"50","author":"Davies","year":"2000","journal-title":"IUBMB Life"},{"issue":"11","key":"10.1016\/j.psychres.2016.11.021_bib9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.psychres.2004.07.002","article-title":"Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the repeatable battery for the assessment of neuropsychological status","volume":"129","author":"Dickerson","year":"2004","journal-title":"Psychiatry Res."},{"issue":"9\u201310","key":"10.1016\/j.psychres.2016.11.021_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/ars.2005.7.1223","article-title":"Oxidative and antioxidative potential of brain microglial cells","volume":"7","author":"Dringen","year":"2005","journal-title":"Antioxid. Redox Signal"},{"issue":"6","key":"10.1016\/j.psychres.2016.11.021_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/pcn.12244","article-title":"Level of plasma thioredoxin in male patients with manic episode at initial and post\u2010electroconvulsive or antipsychotic treatment","volume":"69","author":"Genc","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2016.11.021_bib13","unstructured":"Golden, C.J., 1978. Stroop Colour and Word Test. Stoelting Publishing House, Chicago."},{"key":"10.1016\/j.psychres.2016.11.021_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.11.021_bib16","doi-asserted-by":"crossref","unstructured":"Guy, W., 1976. Clinical global impression scale. The ECDEU Assessment Manual for Psychopharmacology-Revised. Volume DHEW Publ No ADM 76 338, 218-222.","DOI":"10.1037\/e591322011-001"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","article-title":"Thioredoxin","volume":"54","author":"Holmgren","year":"1985","journal-title":"Annu Rev. Biochem."},{"issue":"15","key":"10.1016\/j.psychres.2016.11.021_bib18","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1523\/JNEUROSCI.5566-05.2006","article-title":"Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase","volume":"26","author":"Hu","year":"2006","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.psychres.2016.11.021_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.pnpbp.2011.05.007","article-title":"Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients","volume":"35","author":"Kartalci","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2016.11.021_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.psychres.2016.11.021_bib21","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/sj.npp.1301072","article-title":"Baseline neurocognitive deficits in the CATIE schizophrenia trial","volume":"31","author":"Keefe","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2016.11.021_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/schbul\/sbu070","article-title":"Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage","volume":"40","author":"Kochunov","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.psychres.2016.11.021_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S0033291710001042","article-title":"Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder","volume":"41","author":"Lewandowski","year":"2011","journal-title":"Psychol. Med."},{"issue":"14","key":"10.1016\/j.psychres.2016.11.021_bib24","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1073\/pnas.1332809100","article-title":"Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase\/catalase mimetics","volume":"100","author":"Liu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.psychres.2016.11.021_bib25","first-page":"159","article-title":"Free radical involvement in neuropsychiatric illnesses","volume":"31","author":"Lohr","year":"1995","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.psychres.2016.11.021_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2014.03.025","article-title":"Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study","volume":"156","author":"Mart\u00ednez-Cengotitabengoa","year":"2014","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2016.11.021_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0014708","article-title":"Neurocognition in first-episode schizophrenia: a meta-analytic review","volume":"23","author":"Mesholam-Gately","year":"2009","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.psychres.2016.11.021_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pneurobio.2011.07.007","article-title":"Neuroimaging and the question of neurodegeneration in schizophrenia","volume":"95","author":"Meyer-Lindenberg","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.psychres.2016.11.021_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1096\/fj.02-0448fje","article-title":"Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress","volume":"17","author":"Nagai","year":"2003","journal-title":"FASEB J."},{"issue":"5\u20136","key":"10.1016\/j.psychres.2016.11.021_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2005.7.823","article-title":"Thioredoxin and its related molecules: update 2005","volume":"7","author":"Nakamura","year":"2005","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.psychres.2016.11.021_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0306-4522(01)00374-8","article-title":"Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents","volume":"107","author":"Nicolle","year":"2001","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.psychres.2016.11.021_bib34","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.pnpbp.2011.03.012","article-title":"Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia","volume":"35","author":"Owe-Larsson","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.psychres.2016.11.021_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","article-title":"Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"41","author":"Pillai","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000369214","article-title":"Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls","volume":"15","author":"Rao","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.psychres.2016.11.021_bib38","doi-asserted-by":"crossref","unstructured":"Reitan, R.M., 1958. Validity of the trail making test as a indication of organic brain.","DOI":"10.2466\/PMS.8.7.271-276"},{"key":"10.1016\/j.psychres.2016.11.021_bib39","series-title":"L'examen Clinique en Psychologie","author":"Rey","year":"1964"},{"issue":"51","key":"10.1016\/j.psychres.2016.11.021_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1192\/bjp.191.51.s43","article-title":"Relationship between subjective and objective cognitive function in the early and late prodrome","volume":"191","author":"Schultze-Lutter","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0193-953X(02)00084-9","article-title":"Cognitive function in schizophrenia: deficits, functional consequences, and future treatment","volume":"26","author":"Sharma","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.psychres.2016.11.021_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2015.04.033","article-title":"Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke","volume":"1615","author":"Wang","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2016.11.021_bib43","series-title":"Wechsler Memory Scale\u2014Revised Manual","author":"Wechsler","year":"1987"},{"issue":"7","key":"10.1016\/j.psychres.2016.11.021_bib44","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal"},{"issue":"1","key":"10.1016\/j.psychres.2016.11.021_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.04.009","article-title":"Plasma total antioxidant status and cognitive impairments in schizophrenia","volume":"139","author":"Zhang","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.psychres.2016.11.021_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.schres.2012.11.017","article-title":"Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls","volume":"143","author":"Zhang","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.psychres.2016.11.021_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2009.05.016","article-title":"The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients","volume":"113","author":"Zhang","year":"2009","journal-title":"Schizophr. Res."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116310241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116310241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T09:45:44Z","timestamp":1621071944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116310241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":47,"alternative-id":["S0165178116310241"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.11.021","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}